BioStock: Cereno reports positive data from patient case study
Cereno Scientific has reported positive data received from a patient case study from the ongoing phase II trial with lead candidate CS1 in pulmonary arterial hypertension. The company’s CEO Sten R Sörensen passed by the BioStock Studio to comment on the significance of the results.
Watch the interview with CEO Sten R Sörensen at biostock.se
Cereno reports positive data from patient case study - BioStock
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/